Which has the lower trailing P/E, BMY or CVS?

BMY has the lower trailing P/E: BMY trades at 14.02 and CVS at 25.04. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or CVS?

Over the past five years, CVS grew revenue faster — BMY at a 2.08% CAGR versus CVS at 8.32%.

Does BMY or CVS pay a bigger dividend?

BMY yields 3.94% and CVS yields 2.79% based on trailing dividends and the latest price.

Is BMY or CVS more profitable?

BMY runs the higher net margin — BMY at 18.87% versus CVS at 1.18%.

How have BMY and CVS total returns compared?

Over the past 10 years, BMY delivered 5.01% and CVS delivered 3.54% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs CVS Health Corp. (CVS)

A side-by-side comparison of Bristol-Myers Squibb Company and CVS Health Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$130.00B

$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

CVS

CVS Health Corp.

$120.78B

$94.66HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — BMY vs CVS

growth of $100 · dividends reinvested · last 10y

BMY +64.7% (+5.1%/yr)CVS +39.3% (+3.4%/yr)BMY compounded faster over this window

BMY CVS

BMY vs CVS: by the numbers

•BMY is the larger company ($130.00B vs $120.78B market cap).
•BMY trades at the lower trailing earnings multiple (14.02 vs 25.04 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 1.18% net margin).
•CVS grew revenue faster over the past five years (8.32% vs 2.08% CAGR).
•BMY pays the higher dividend yield (3.94% vs 2.79%).

Metrics side by side

Valuation

Metric	BMY	CVS
P/E ratio	14.02	25.04
Forward P/E	9.18	11.83
P/S ratio	2.64	0.29
P/B ratio	5.82	1.52
EV / EBITDA	9.71	14.50
FCF yield	8.80%	9.74%

Profitability

Metric	BMY	CVS
Gross margin	70.16%	14.15%
Operating margin	28.27%	2.00%
Net margin	18.87%	1.18%
ROE	41.59%	6.16%
ROIC	15.47%	4.14%

Dividends

Metric	BMY	CVS
Dividend yield	3.94%	2.79%
Payout ratio	55.29%	70.37%

Growth (annualized)

Metric	BMY	CVS
Revenue CAGR (5Y)	2.08%	8.32%
EPS CAGR (5Y)	9.38%	-23.89%
FCF CAGR (5Y)	-0.95%	-10.28%
Total return CAGR (5Y)	4.39%	6.05%

Frequently asked

Which has the lower trailing P/E, BMY or CVS?: BMY has the lower trailing P/E: BMY trades at 14.02 and CVS at 25.04. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or CVS?: Over the past five years, CVS grew revenue faster — BMY at a 2.08% CAGR versus CVS at 8.32%.
Does BMY or CVS pay a bigger dividend?: BMY yields 3.94% and CVS yields 2.79% based on trailing dividends and the latest price.
Is BMY or CVS more profitable?: BMY runs the higher net margin — BMY at 18.87% versus CVS at 1.18%.
How have BMY and CVS total returns compared?: Over the past 10 years, BMY delivered 5.01% and CVS delivered 3.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full CVS analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio CVS Health P/E ratio Bristol-Myers Squibb dividend yield CVS Health dividend yield Bristol-Myers Squibb ROE CVS Health ROE Bristol-Myers Squibb operating margin CVS Health operating margin Bristol-Myers Squibb revenue growth CVS Health revenue growth Bristol-Myers Squibb free cash flow CVS Health free cash flow

Bristol-Myers Squibb & CVS Health appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.